Related Experiment Video
Updated: May 1, 2026
Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
The Effects of Neonatal Zingerone Administration and Adolescent Alcohol Exposure on Bone Health Markers and
Brunhildé De Vos1, Bernice Asiedu1, Anna M Joubert1
1Department of Human Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa, up.ac.za.
Insights
Neonatal zingerone offered limited protection against alcohol-induced bone damage. Combined neonatal zingerone and alcohol exposure showed variable effects, highlighting the need for optimized therapeutic strategies for bone health.
Area of Science:
- Bone biology and developmental toxicology.
- Pharmacology of natural antioxidants.
Background:
- Neonatal alcohol exposure negatively impacts long-term development, particularly metabolism and bone health.
- Zingerone, an antioxidant, may counteract alcohol-induced oxidative stress and inflammation, potentially benefiting bone health.
Purpose of the Study:
- To evaluate zingerone's effects on bone turnover and morphometry in neonatal rats exposed to alcohol.
- To investigate the protective potential of zingerone against alcohol-induced bone alterations during critical developmental periods.
Main Methods:
- Neonatal Sprague-Dawley rats received water, zingerone, alcohol, or zingerone-alcohol combination for 9 days.
- Adolescent rats received a secondary alcohol insult.
- Bone formation biomarkers (BALP, osteocalcin, P1NP) and microcomputed tomography assessed bone morphometry.
Main Results:
- Neonatal zingerone and alcohol exposure increased plasma bone formation markers (BALP, P1NP).
- Adolescent alcohol exposure impaired bone mass, reduced bone mass-to-length ratios, and altered trabecular architecture.
- Neonatal zingerone alone provided minimal protection against alcohol's detrimental effects on bone.
Conclusions:
- Adolescent alcohol exposure significantly impacts bone health, with neonatal zingerone showing limited protective capacity.
- The combination of neonatal zingerone and alcohol yielded inconsistent results, suggesting context-dependent effects.
- Further research is needed to determine optimal zingerone dosage, timing, and its clinical efficacy for bone protection.
Objective:
Neonatal interventions influence long-term developmental outcomes, with excessive alcohol consumption impairing metabolism and bone health. Zingerone, a natural antioxidant, may possess health benefits against alcohol-induced oxidative damage and inflammation, promoting bone health. This study investigates the effects of zingerone on markers of bone turnover and morphometry in neonatal rats subjected to alcohol exposure during critical developmental stages.
Methods:
Ten-day-old male Sprague-Dawley rats (N = 35) were randomized and treated with water (C), zingerone (Z) (40 mg/kg), alcohol (A) (1 g/kg) or zingerone-alcohol combination (ZA) for 9 days. During adolescence, rats received either water or a secondary A insult (20% v/v) for 54 days. At termination, ELISA kits were used to measure biomarkers of bone formation (bone-specific alkaline phosphatase, osteocalcin, and procollagen Type I N-terminal propeptide). Bone morphology and morphometry was assessed using microcomputed tomography.
Results:
Neonatal zingerone (Z + A; ZA + A) and double alcohol exposure (A + A) significantly increased plasma BALP and P1NP levels (p < 0.05). Tibial length remained unchanged across groups (p > 0.05). Neonatal zingerone with adolescent alcohol (Z + A) significantly reduced tibial mass, bone mass-to-length ratios, and trabecular architecture near the growth plate (p < 0.05). Neonatal and adolescent administration of alcohol (A + A) significantly increased midshaft cortical thickness (p < 0.05).
Conclusion:
Adolescent alcohol treatment impaired bone function and morphology, neonatal zingerone alone offering limited protection. Coadministration of zingerone with alcohol neonatally produced variable and context-dependent changes with no clear evidence of sustained protection against the effects of alcohol exposure. These findings underscore the importance of optimizing timing, dosage, and combination therapies for bone health. Further studies are warranted to clarify whether zingerone has clinically meaningful bone-protective effects.
